Company Updates

January 13, 2016 The investment will support scale up of Atomo’s global health activities, focusing on continued rollout of its award winning AtomoRapid™ HIV test and launch of an affordable HIV self-test offering unmatched performance The Global Health Investment Fund (GHIF) announced today that it has provided a US$6 million [A$8.5 million] loan to Atomo […]

Cape Town, South Africa The Desmond Tutu HIV Foundation has successfully completed an acceptability and usability study on HIV self-testing using the Atomo HIV Self Test. With 224 participants enrolled, the study provides valuable information into one potential avenue to rapidly expand HIV testing services, which is the gateway to HIV prevention. The participants were […]

Spotlight Reporting have appointed Sydney-based David New as our Director of Strategic Relationships.  David comes to us with an impressive track record in software, from an MD role at Attache, National Sales Director at Xero and most recently as Country Manager, Australia and New Zealand at Receipt Bank. ABOUT SPOTLIGHT REPORTING Spotlight Reporting is an […]

14th January 2016, ASX Announcement Clinical stage oncology company Prescient Therapeutics Ltd (PTX) has appointed a highly respected US-based specialist in myeloid malignancies Dr Thomas Prebet MD, PhD of Yale Cancer Center to the PTX Scientific Advisory Board (SAB). Dr Prebet is the Assistant Director of Myeloid Malignancy Research at Yale, where he is looking […]

14th January 2016, ASX Announcement Altech Chemicals Limited (Altech/the Company) is pleased to announce the appointment of Mr Martin Ma as the Company’s sales and marketing manager (China). This key appointment marks an important step as the Company progresses its marketing strategy for the high purity alumina (HPA) project specifically for the Asia Pacific region. […]

In December 2015, US company ZZ Biotech LLC completed the acquisition of Bioatrix Pty Ltd. Based in Houston, ZZ Biotech is in a Phase 2 trial with 3K3A-Activated Protein C (‘3K3A-APC’) in acute ischemic stroke patients, supported by a grant from the National Institute for Neurological Disease and Stroke.  ZZ Biotech’s Australian subsidiary is presently […]

14th January 2016, Sydney Morning Herald by John McDuling An investment fund backed by billionaire Bill Gates is pouring $6 million into a Sydney HIV and malaria testing company. The US based Global Health Investment Fund (GHIF), which was set up by the Bill and Melinda Gates Foundation and investment bank JPMorgan in 2013, will […]

DomaCom Ltd, an Australian company which has developed the first and only Regulated Fractional Property Investment platform in the country, have raised $8m cash in their pre-IPO fundraising round which is due to close Friday January 15, 2016 The raising will allow DomaCom to proceed to IPO and fund its operation to break even. The […]

12th January 2016, ASX Announcement Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (Crowd Mobile or the Company) is pleased to announce it has executed agreements to launch into Asian countries India, Philippines, Thailand and Indonesia, as the Company  continues its global expansion strategy. Commenting on the Asia launch, Crowd Mobile CEO Mr Domenic Carosa […]